Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells.

Jeon JM, Kwon OK, Na AY, Sung EJ, Cho IJ, Kim M, Yea SS, Chun SY, Lee JH, Ha YS, Kwon TG, Lee S.

PLoS One. 2019 Aug 12;14(8):e0220807. doi: 10.1371/journal.pone.0220807. eCollection 2019.

2.

A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.

Choi JH, Kim KH, Roh KH, Jung H, Lee A, Lee JY, Song JY, Park SJ, Kim I, Lee WS, Seo SK, Choi IW, Fu YX, Yea SS, Park S.

Oncoimmunology. 2018 Jan 16;7(5):e1421890. doi: 10.1080/2162402X.2017.1421890. eCollection 2018.

3.

3,3'-Diindolylmethane inhibits VEGF expression through the HIF-1α and NF-κB pathways in human retinal pigment epithelial cells under chemical hypoxic conditions.

Park H, Lee DS, Yim MJ, Choi YH, Park S, Seo SK, Choi JS, Jang WH, Yea SS, Park WS, Lee CM, Jung WK, Choi IW.

Int J Mol Med. 2015 Jul;36(1):301-8. doi: 10.3892/ijmm.2015.2202. Epub 2015 May 5.

PMID:
25955241
4.

Caffeic acid phenethyl ester inhibits the inflammatory effects of interleukin-1β in human corneal fibroblasts.

Yang JW, Jung WK, Lee CM, Yea SS, Choi YH, Kim GY, Lee DS, Na G, Park SG, Seo SK, Choi JS, Lee YM, Park WS, Choi IW.

Immunopharmacol Immunotoxicol. 2014 Oct;36(5):371-7. doi: 10.3109/08923973.2014.953957. Epub 2014 Aug 25.

PMID:
25151996
5.

Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.

Yea SS, So L, Mallya S, Lee J, Rajasekaran K, Malarkannan S, Fruman DA.

PLoS One. 2014 Jun 10;9(6):e99486. doi: 10.1371/journal.pone.0099486. eCollection 2014.

6.

Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization.

Lee CM, Jung WK, Na G, Lee DS, Park SG, Seo SK, Yang JW, Yea SS, Lee YM, Park WS, Choi IW.

Cutan Ocul Toxicol. 2015 Mar;34(1):53-60. doi: 10.3109/15569527.2014.903573. Epub 2014 Apr 22.

PMID:
24754407
7.

CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.

Wu Z, Lee D, Joo J, Shin JH, Kang W, Oh S, Lee DY, Lee SJ, Yea SS, Lee HS, Lee T, Liu KH.

Antimicrob Agents Chemother. 2013 Nov;57(11):5448-56. doi: 10.1128/AAC.00843-13. Epub 2013 Aug 19.

8.

Achieving cancer cell death with PI3K/mTOR-targeted therapies.

Yea SS, Fruman DA.

Ann N Y Acad Sci. 2013 Mar;1280:15-8. doi: 10.1111/nyas.12028. Review.

9.

Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.

So L, Yea SS, Oak JS, Lu M, Manmadhan A, Ke QH, Janes MR, Kessler LV, Kucharski JM, Li LS, Martin MB, Ren P, Jessen KA, Liu Y, Rommel C, Fruman DA.

J Biol Chem. 2013 Feb 22;288(8):5718-31. doi: 10.1074/jbc.M112.379446. Epub 2012 Dec 28.

10.

Expression of galectin-9 by IFN-γ stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways.

Park WS, Jung WK, Park SK, Heo KW, Kang MS, Choi YH, Kim GY, Park SG, Seo SK, Yea SS, Liu KH, Shim EB, Kim DJ, Her M, Choi IW.

Biochem Biophys Res Commun. 2011 Jul 29;411(2):259-64. doi: 10.1016/j.bbrc.2011.06.110. Epub 2011 Jun 23.

PMID:
21723260
11.

Cell signaling. New mTOR targets Grb attention.

Yea SS, Fruman DA.

Science. 2011 Jun 10;332(6035):1270-1. doi: 10.1126/science.1208071. No abstract available.

PMID:
21659593
12.

Magnolol Inhibits LPS-induced NF-κB/Rel Activation by Blocking p38 Kinase in Murine Macrophages.

Li MH, Kothandan G, Cho SJ, Huong PT, Nan YH, Lee KY, Shin SY, Yea SS, Jeon YJ.

Korean J Physiol Pharmacol. 2010 Dec;14(6):353-8. doi: 10.4196/kjpp.2010.14.6.353. Epub 2010 Dec 31.

13.

Cilostazol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms.

Park WS, Jung WK, Lee DY, Moon C, Yea SS, Park SG, Seo SK, Park C, Choi YH, Kim GY, Choi JS, Choi IW.

Int Immunopharmacol. 2010 Sep;10(9):1077-85. doi: 10.1016/j.intimp.2010.06.008. Epub 2010 Jun 19.

PMID:
20601185
14.

Cilostazol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases.

Jung WK, Lee DY, Park C, Choi YH, Choi I, Park SG, Seo SK, Lee SW, Yea SS, Ahn SC, Lee CM, Park WS, Ko JH, Choi IW.

Br J Pharmacol. 2010 Mar;159(6):1274-85. doi: 10.1111/j.1476-5381.2009.00615.x. Epub 2010 Jan 28.

15.

Constituents of Corydalis heterocarpa and their anti-proliferative effects on human cancer cells.

Kim YA, Kong CS, Yea SS, Seo Y.

Food Chem Toxicol. 2010 Feb;48(2):722-8. doi: 10.1016/j.fct.2009.12.002. Epub 2009 Dec 21.

PMID:
20026161
16.

Evaluation of Salicornia herbacea as a potential antioxidant and anti-inflammatory agent.

Kim YA, Kong CS, Um YR, Lim SY, Yea SS, Seo Y.

J Med Food. 2009 Jun;12(3):661-8. doi: 10.1089/jmf.2008.1072.

PMID:
19627218
17.

The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.

Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.

Life Sci. 2009 Jul 3;85(1-2):46-53. doi: 10.1016/j.lfs.2009.04.010. Epub 2009 May 3.

PMID:
19409914
18.

Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways.

Jung WK, Ahn YW, Lee SH, Choi YH, Kim SK, Yea SS, Choi I, Park SG, Seo SK, Lee SW, Choi IW.

Food Chem Toxicol. 2009 Feb;47(2):410-7. doi: 10.1016/j.fct.2008.11.041. Epub 2008 Dec 11.

PMID:
19111593
19.

Amplification of an RNA ligase ribozyme under alternating temperature conditions.

Kim KS, Oh S, Yea SS, Yoon MY, Kim DE.

FEBS Lett. 2008 Aug 6;582(18):2745-52. doi: 10.1016/j.febslet.2008.07.013. Epub 2008 Jul 14.

20.

Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.

Jung WK, Choi I, Lee DY, Yea SS, Choi YH, Kim MM, Park SG, Seo SK, Lee SW, Lee CM, Park YM, Choi IW.

Int J Biochem Cell Biol. 2008;40(11):2572-82. doi: 10.1016/j.biocel.2008.05.005. Epub 2008 May 15.

PMID:
18571461
21.

Identification and characterization of potent CYP2B6 inhibitors in Woohwangcheongsimwon suspension, an herbal preparation used in the treatment and prevention of apoplexy in Korea and China.

Kim H, Kim KB, Ku HY, Park SJ, Choi H, Moon JK, Park BS, Kim JH, Yea SS, Lee CH, Lee HS, Shin JG, Liu KH.

Drug Metab Dispos. 2008 Jun;36(6):1010-5. doi: 10.1124/dmd.107.019612. Epub 2008 Mar 10. Erratum in: Drug Metab Dispos. 2008 Aug;36(8):1736. Park, Soo Jin [corrected to Park, Soo-Jin].

PMID:
18332082
22.

Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma.

Jung WK, Lee DY, Choi YH, Yea SS, Choi I, Park SG, Seo SK, Lee SW, Lee CM, Kim SK, Jeon YJ, Choi IW.

Life Sci. 2008 Mar 26;82(13-14):797-805. doi: 10.1016/j.lfs.2008.01.014. Epub 2008 Feb 5.

PMID:
18299139
23.

Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population.

Yea SS, Lee SS, Kim WY, Liu KH, Kim H, Shon JH, Cha IJ, Shin JG.

Ther Drug Monit. 2008 Feb;30(1):23-34. doi: 10.1097/FTD.0b013e3181633824.

PMID:
18223459
24.

Bisindoylmaleimide I suppresses adipocyte differentiation through stabilization of intracellular beta-catenin protein.

Cho M, Park S, Gwak J, Kim DE, Yea SS, Shin JG, Oh S.

Biochem Biophys Res Commun. 2008 Feb 29;367(1):195-200. doi: 10.1016/j.bbrc.2007.12.147. Epub 2008 Jan 2.

PMID:
18174026
25.

Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis.

Park SG, Lee DY, Seo SK, Lee SW, Kim SK, Jung WK, Kang MS, Choi YH, Yea SS, Choi I, Choi IW.

Toxicol Appl Pharmacol. 2008 Jan 1;226(1):22-9. Epub 2007 Aug 17.

PMID:
17884125
26.

Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling.

Kim SK, Lee DY, Jung WK, Kim JH, Choi I, Park SG, Seo SK, Lee SW, Lee CM, Yea SS, Choi YH, Choi IW.

Biomed Pharmacother. 2008 Jun;62(5):289-96. Epub 2007 Aug 10.

PMID:
17804193
27.

Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-kappaB, ERK1/2, and p38 kinase.

Choi CY, Park KR, Lee JH, Jeon YJ, Liu KH, Oh S, Kim DE, Yea SS.

Eur J Pharmacol. 2007 Dec 8;576(1-3):151-9. Epub 2007 Jul 26.

PMID:
17698059
28.

Replication of an RNA ligase ribozyme under alternating temperature condition.

Kim KS, Choi WH, Choi BR, Oh S, Yea SS, Yoon MY, Kim DE.

FEBS Lett. 2007 Aug 21;581(21):4065-72. Epub 2007 Jul 30. Retraction in: Eklund H, Wieland F. FEBS Lett. 2007 Dec 11;581(29):5733.

29.

Suppression of interleukin-2 gene expression by isoeugenol is mediated through down-regulation of NF-AT and NF-kappaB.

Park KR, Lee JH, Choi C, Liu KH, Seog DH, Kim YH, Kim DE, Yun CH, Yea SS.

Int Immunopharmacol. 2007 Sep;7(9):1251-8. Epub 2007 Jun 15.

PMID:
17630204
30.

Expression of cyclooxygenase-2 and 5-lipoxygenase in nasal polyps associated with interleukin-4 promoter polymorphism -590.

Park SK, Heo KW, Jung H, Yea SS, Yang YI.

Otolaryngol Head Neck Surg. 2006 Dec;135(6):928-32.

PMID:
17141086
31.

Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population.

Yea SS, Yang YI, Park SK, Jang WH, Lee SS, Seog DH, Park YH, Chun JH.

Am J Rhinol. 2006 Sep-Oct;20(5):550-3.

PMID:
17063753
32.

Gene expression analysis of primary normal human hepatocytes infected with human hepatitis B virus.

Ryu HM, Park SG, Yea SS, Jang WH, Yang YI, Jung G.

World J Gastroenterol. 2006 Aug 21;12(31):4986-95.

33.

Inhibitory effect of anethole on T-lymphocyte proliferation and interleukin-2 production through down-regulation of the NF-AT and AP-1.

Yea SS, Jeong HS, Choi CY, Park KR, Oh S, Shin JG, Yun CH.

Toxicol In Vitro. 2006 Oct;20(7):1098-105. Epub 2006 Mar 13.

PMID:
16531003
34.

In vitro metabolism of a new cardioprotective agent, KR-32570, in human liver microsomes.

Kim H, Kang S, Kim H, Yoon YJ, Cha EY, Lee HS, Kim JH, Yea SS, Lee SS, Shin JG, Liu KH.

Rapid Commun Mass Spectrom. 2006;20(5):837-43.

PMID:
16470676
35.

Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.

Cho M, Gwak J, Park S, Won J, Kim DE, Yea SS, Cha IJ, Kim TK, Shin JG, Oh S.

FEBS Lett. 2005 Aug 15;579(20):4213-8.

36.

MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populations.

Lee SS, Kim SY, Kim WY, Thi-Le H, Yoon YR, Yea SS, Shin JG.

Ther Drug Monit. 2005 Aug;27(4):531-5.

PMID:
16044113
37.

Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.

Kaplan BL, Ouyang Y, Herring A, Yea SS, Razdan R, Kaminski NE.

Toxicol Appl Pharmacol. 2005 Jun 1;205(2):107-15. Epub 2005 Jan 1.

PMID:
15893538
38.

Genetic polymorphism of CYP2C9 in a Vietnamese Kinh population.

Lee SS, Kim KM, Thi-Le H, Yea SS, Cha IJ, Shin JG.

Ther Drug Monit. 2005 Apr;27(2):208-10.

PMID:
15795654
39.

Roles of human liver cytochrome P450 3A4 and 1A2 enzymes in the oxidation of myristicin.

Yun CH, Lee HS, Lee HY, Yim SK, Kim KH, Kim E, Yea SS, Guengerich FP.

Toxicol Lett. 2003 Feb 3;137(3):143-50.

PMID:
12523956
40.

Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection.

Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH.

J Clin Pathol. 2001 Sep;54(9):703-6.

41.

Microcystin-induced down-regulation of lymphocyte functions through reduced IL-2 mRNA stability.

Yea SS, Kim HM, Oh HM, Paik KH, Yang KH.

Toxicol Lett. 2001 May 31;122(1):21-31.

PMID:
11397554
42.

The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers.

Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH.

Cancer Lett. 2001 May 10;166(1):41-6.

PMID:
11295285
43.

Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation.

Lee M, Yea SS, Jeon YJ.

Int J Immunopharmacol. 2000 Aug;22(8):615-21.

PMID:
10988356
45.

Suppression of IL-2 and IL-4 gene expression by nodularin through the reduced NF-AT binding activity.

Yea SS, Kim HM, Jeon YJ, Oh HM, Jeong HG, Yang KH.

Toxicol Lett. 2000 Apr 3;114(1-3):215-24.

PMID:
10713487
46.
47.
48.

Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.

Han SH, Yea SS, Jeon YJ, Yang KH, Kaminski NE.

J Pharmacol Exp Ther. 1998 Dec;287(3):1105-12.

PMID:
9864299
49.

Inhibition of NF-kappa B/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression.

Jeon YJ, Han SH, Lee YW, Yea SS, Yang KH.

Biochem Mol Biol Int. 1998 Jul;45(3):435-41.

PMID:
9679644

Supplemental Content

Support Center